SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1.30 Cr | ₹-1.43 Cr | ₹0.28 Cr | ₹-0.02 Cr | ₹0.05 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1.30 Cr |
| Mar2024 | ₹-1.43 Cr |
| Mar2023 | ₹0.28 Cr |
| Mar2022 | ₹-0.02 Cr |
| Mar2021 | ₹0.05 Cr |
How is Deferred Tax Assets / Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.30 Cr | Negative | |
| Mar2024 | ₹-1.43 Cr | Negative | |
| Mar2023 | ₹0.28 Cr | Positive | |
| Mar2022 | ₹-0.02 Cr | Negative | |
| Mar2021 | ₹0.05 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹100.0 Cr | -5.3% | -15.1% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -5.3% |
-15.1% |
-25.9% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses